Published in Kidney Int on December 31, 2008
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med (2013) 7.98
Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol (2010) 3.85
Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol (2012) 2.58
Estimated GFR associates with cardiovascular risk factors independently of measured GFR. J Am Soc Nephrol (2011) 2.25
Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension (2011) 2.13
Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. Am J Kidney Dis (2011) 2.11
Associations of blood lead with estimated glomerular filtration rate using MDRD, CKD-EPI and serum cystatin C-based equations. Nephrol Dial Transplant (2011) 2.04
Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. Intensive Care Med (2010) 2.01
Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int (2012) 1.93
A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis (2012) 1.90
Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney Int (2010) 1.88
Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons. Am J Kidney Dis (2010) 1.84
Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis (2012) 1.81
The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli. Kidney Int (2012) 1.68
GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD. Am J Kidney Dis (2015) 1.64
Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study. Crit Care (2014) 1.57
Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates. Am J Kidney Dis (2013) 1.54
Cystatin C and risk of hip fractures in older women. J Bone Miner Res (2013) 1.54
Advances in glomerular filtration rate-estimating equations. Curr Opin Nephrol Hypertens (2010) 1.49
Filtration markers may have prognostic value independent of glomerular filtration rate. J Am Soc Nephrol (2011) 1.43
Arterial stiffness in mild-to-moderate CKD. J Am Soc Nephrol (2009) 1.41
Blood pressure and chronic kidney disease progression in a multi-racial cohort: the Multi-Ethnic Study of Atherosclerosis. J Hum Hypertens (2013) 1.38
Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals. J Acquir Immune Defic Syndr (2012) 1.38
Obesity and change in estimated GFR among older adults. Am J Kidney Dis (2009) 1.37
Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis (2011) 1.30
Urinary biomarkers and renal recovery in critically ill patients with renal support. Clin J Am Soc Nephrol (2011) 1.17
The applicability of eGFR equations to different populations. Nat Rev Nephrol (2013) 1.10
Comparing GFR Estimating Equations Using Cystatin C and Creatinine in Elderly Individuals. J Am Soc Nephrol (2014) 1.10
The emerging role of Klotho in clinical nephrology. Nephrol Dial Transplant (2012) 1.08
Estimation of glomerular filtration rate from serum creatinine and cystatin C in octogenarians and nonagenarians. BMC Nephrol (2013) 1.08
Association between cystatin C and inflammation in patients with essential hypertension. Clin Exp Nephrol (2010) 1.07
Cystatin C: a step forward in assessing kidney function and cardiovascular risk. Heart Fail Rev (2012) 1.06
Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults. Am J Kidney Dis (2013) 1.05
Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test. Nephrol Dial Transplant (2014) 1.02
Sickle cell nephropathy: challenging the conventional wisdom. Pediatr Nephrol (2011) 0.99
Predicting the glomerular filtration rate in bariatric surgery patients. Am J Nephrol (2013) 0.98
Cystatin C- and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S. Diabetes Care (2013) 0.98
How to manage HIV-infected patients with chronic kidney disease in the HAART era. Clin Exp Nephrol (2012) 0.97
Performance of serum cystatin C versus serum creatinine as a marker of glomerular filtration rate as measured by inulin renal clearance. Clin Exp Nephrol (2011) 0.96
Reference ranges for serum cystatin C measurements in Japanese children by using 4 automated assays. Clin Exp Nephrol (2013) 0.96
Inflammatory markers and risk of hip fracture in older white women: the study of osteoporotic fractures. J Bone Miner Res (2014) 0.95
Differences in urine cadmium associations with kidney outcomes based on serum creatinine and cystatin C. Environ Res (2011) 0.94
Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease. J Lipid Res (2010) 0.92
Creatinine-or cystatin C-based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease. BMC Nephrol (2013) 0.92
Kidney function and mortality in octogenarians: Cardiovascular Health Study All Stars. J Am Geriatr Soc (2012) 0.91
Estimated GFR and risk of hip fracture in older men: comparison of associations using cystatin C and creatinine. Am J Kidney Dis (2013) 0.91
Assessing glomerular filtration rate in hospitalized patients: a comparison between CKD-EPI and four cystatin C-based equations. Clin J Am Soc Nephrol (2011) 0.90
Creatinine and cystatin C: what are the values? Kidney Int (2009) 0.89
Change in novel filtration markers and risk of ESRD. Am J Kidney Dis (2014) 0.89
Clinical utility of creatinine- and cystatin C-based definition of renal function for risk prediction of primary cardiovascular events in patients with diabetes. Diabetes Care (2012) 0.88
Assessment and diagnosis of renal dysfunction in the ICU. Chest (2012) 0.87
Factors other than the glomerular filtration rate that determine the serum beta-2-microglobulin level. PLoS One (2013) 0.87
Methods of assessing renal function. Pediatr Nephrol (2013) 0.86
Estimated glomerular filtration rate as an independent predictor of atherosclerotic vascular disease in older women. BMC Nephrol (2012) 0.86
Apolipoprotein E and kidney function in older adults. Clin Nephrol (2012) 0.86
Comparisons between the 2012 new CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equations and other four approved equations. PLoS One (2014) 0.85
Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD. Am J Kidney Dis (2016) 0.85
Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification. Int J Clin Exp Pathol (2014) 0.85
Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis. Clin Exp Nephrol (2012) 0.84
Screening for chronic kidney disease in HIV-infected patients. Adv Chronic Kidney Dis (2010) 0.83
Cystatin C is not a good candidate biomarker for HNF1A-MODY. Acta Diabetol (2012) 0.83
Kidney function of HIV-infected children in Lagos, Nigeria: using Filler's serum cystatin C-based formula. J Int AIDS Soc (2010) 0.83
Cystatin C and long term risk of community-acquired sepsis: a population-based cohort study. BMC Nephrol (2015) 0.83
Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy. Endocrine (2012) 0.83
Cystatin C and frailty in older men. J Am Geriatr Soc (2013) 0.83
Kidney Function and Fracture Risk: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis (2015) 0.83
Diagnosis and management of chronic kidney disease in the elderly: a field of ongoing debate. Aging Dis (2012) 0.81
The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol (2016) 0.81
Proteinuria, (99m) Tc-DTPA Scintigraphy, Creatinine-, Cystatin- and Combined-Based Equations in the Assessment of Chronic Kidney Disease. ISRN Nephrol (2014) 0.80
Nonparametric multistate representations of survival and longitudinal data with measurement error. Stat Med (2012) 0.80
Serum cystatin C is a poor biomarker for diagnosing acute kidney injury in critically-ill children. Indian J Crit Care Med (2013) 0.80
Acute kidney injury after cardiovascular surgery: an overview. Methodist Debakey Cardiovasc J (2012) 0.80
Beta-2 microglobulin-based equation for estimating glomerular filtration rates in Japanese children and adolescents. Clin Exp Nephrol (2014) 0.80
International Collaboration for the Epidemiology of eGFR in Low and Middle Income Populations - Rationale and core protocol for the Disadvantaged Populations eGFR Epidemiology Study (DEGREE). BMC Nephrol (2017) 0.79
Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s. J Acquir Immune Defic Syndr (2015) 0.79
Fracture risk in CKD. Clin J Am Soc Nephrol (2013) 0.79
Associations of proanthocyanidin intake with renal function and clinical outcomes in elderly women. PLoS One (2013) 0.79
Cystatin C Is Not Causally Related to Coronary Artery Disease. PLoS One (2015) 0.79
Cystatin C: a new renal marker and its potential use in small animal medicine. J Vet Intern Med (2014) 0.79
Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis. Clin J Am Soc Nephrol (2016) 0.79
Reference intervals for serum cystatin C and factors influencing cystatin C levels other than renal function in the elderly. PLoS One (2014) 0.78
Association between serum long-chain n-3 and n-6 polyunsaturated fatty acid profiles and glomerular filtration rate assessed by serum creatinine and cystatin C levels in Japanese community-dwellers. J Epidemiol (2015) 0.78
The performance of contemporary cystatin C-based GFR equations in predicting gentamicin clearance. Br J Clin Pharmacol (2015) 0.78
Residual Associations of Inflammatory Markers with eGFR after Accounting for Measured GFR in a Community-Based Cohort without CKD. Clin J Am Soc Nephrol (2015) 0.78
Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney. Am J Kidney Dis (2017) 0.77
β2-microglobulin, cystatin C, and creatinine and risk of symptomatic peripheral artery disease. J Am Heart Assoc (2014) 0.77
Evaluation of a new immunoassay for cystatin C, based on a double monoclonal principle, in men with normal and impaired renal function. Nephrol Dial Transplant (2011) 0.77
The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosis. BMC Nephrol (2015) 0.77
Estimating GFR in adult patients with hematopoietic cell transplant: comparison of estimating equations with an iohexol reference standard. Clin J Am Soc Nephrol (2015) 0.77
Prevalence of kidney disease in anaemia differs by GFR-estimating method: the Third National Health and Nutrition Examination Survey (1988-94). Nephrol Dial Transplant (2010) 0.76
Impact of Growth Hormone on Cystatin C. Nephron Extra (2013) 0.76
A New Equation to Estimate Muscle Mass from Creatinine and Cystatin C. PLoS One (2016) 0.76
Lower serum albumin level is associated with higher fractional excretion of creatinine. Clin Exp Nephrol (2013) 0.75
Association of Frailty based on self-reported physical function with directly measured kidney function and mortality. BMC Nephrol (2015) 0.75
Cystatin C levels are unaltered in patients with diabetes mellitus and normal renal function. Kidney Int (2009) 0.75
Cystatin C in a composite risk score for mortality in patients with infective endocarditis: a cohort study. BMJ Open (2012) 0.75
The association between elevated cystatin C levels with myocardial infarction: a meta-analysis. Int J Clin Exp Med (2015) 0.75
Autologous creatinine clearance in a case of necrotizing fasciitis and anuria. Am J Nephrol (2012) 0.75
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
Prevalence of overweight and obesity in the United States, 1999-2004. JAMA (2006) 72.59
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med (1993) 18.15
Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med (2005) 15.30
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04
Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29
Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med (2006) 6.58
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int (2004) 6.32
Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol (2005) 5.99
Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06
Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int (2006) 4.59
Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med (2005) 4.57
Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest (1999) 4.23
GFR estimation using cystatin C is not independent of body composition. Am J Kidney Dis (2006) 3.81
Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis (2001) 3.68
Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol (2005) 3.28
Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. Am J Kidney Dis (1990) 2.91
Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis (2008) 2.64
Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens (2006) 2.34
Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem (2001) 2.22
Cystatin C--properties and use as diagnostic marker. Adv Clin Chem (2000) 2.16
Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. J Am Soc Nephrol (1999) 1.95
Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest (2005) 1.86
Chronic kidney disease in the elderly--how to assess risk. N Engl J Med (2005) 1.81
Measurement of glomerular filtration rate utilizing a single subcutaneous injection of 125I-iothalamate. Kidney Int (1973) 1.80
Serum cystatin C in the aged: relationships with health status. Am J Kidney Dis (2003) 1.49
Cathepsin s promotes human preadipocyte differentiation: possible involvement of fibronectin degradation. Endocrinology (2006) 1.45
Increased cystatin C concentration in urine of nephrotic children. Pediatr Nephrol (2004) 1.16
Varying coefficients model with measurement error. Biometrics (2007) 1.00
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33
Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis (2003) 15.00
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med (2009) 14.13
Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80
HMDB: the Human Metabolome Database. Nucleic Acids Res (2007) 13.38
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med (2010) 13.25
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29
Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med (2003) 11.25
HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res (2008) 11.23
In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73
Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect (2005) 10.66
Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52
Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2005) 10.42
Duration of red-cell storage and complications after cardiac surgery. N Engl J Med (2008) 10.04
Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care (2002) 10.00
MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet (2008) 9.50
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int (2010) 9.25
A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med (2003) 9.18
Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol (2006) 8.61
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
The case of the misleading funnel plot. BMJ (2006) 8.26
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol (2004) 8.21
Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med (2013) 7.98
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA (2007) 7.93
Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med (2007) 7.90
Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis (2007) 7.86
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79
International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol (2006) 7.51
Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA (2008) 7.50
Common variants in the GDF5-UQCC region are associated with variation in human height. Nat Genet (2008) 7.31
FGF23 induces left ventricular hypertrophy. J Clin Invest (2011) 7.22
Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20
Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis (2002) 7.03
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int (2011) 6.01
Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00
Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet (2008) 5.89
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA (2011) 5.86
Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA (2002) 5.81
Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? J Urol (2008) 5.70
Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med (2009) 5.58
New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58